264 related articles for article (PubMed ID: 29578117)
1. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
[TBL] [Abstract][Full Text] [Related]
2. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Platelet Distribution Width and Fibrinogen in Predicting In-stent Restenosis With Stable Angina and Type 2 Patients With Diabetes Mellitus.
Chai D; Yang X; Wang A; Lu S; Dai Y; Zhou J
Front Cardiovasc Med; 2022; 9():710804. PubMed ID: 35387442
[TBL] [Abstract][Full Text] [Related]
4. Platelet distribution width as the prognostic marker in coronary bifurcation treatment.
Kern A; Gil RJ; Bojko K; Sienkiewicz E; Januszko-Giergielewicz B; Górny J; Bil J
Eur J Clin Invest; 2017 Jul; 47(7):524-530. PubMed ID: 28555728
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.
Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
[TBL] [Abstract][Full Text] [Related]
7. [Impact of platelet distribution width on the extent and long-term outcome of patients with stable coronary artery disease post percutaneous coronary intervention].
Jiang P; Song Y; Xu JJ; Ma YL; Tang XF; Yao Y; Jiang L; Wang HH; Zhang X; Diao XL; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):862-866. PubMed ID: 29081176
[No Abstract] [Full Text] [Related]
8. Platelet distribution width predicts left ventricular dysfunction in patients with acute coronary syndromes treated with percutaneous coronary intervention.
Kowara M; Grodecki K; Huczek Z; Puchta D; Paczwa K; Rymuza B; Zbroński K; Filipiak KJ; Opolski G
Kardiol Pol; 2017; 75(1):42-47. PubMed ID: 27714719
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
10. Visit-to-visit HbA
Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
[TBL] [Abstract][Full Text] [Related]
11. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
12. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Chen T; Sun JL; Zhang J
Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
[TBL] [Abstract][Full Text] [Related]
13. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
[TBL] [Abstract][Full Text] [Related]
14. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
15. Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study.
De Luca G; Secco GG; Verdoia M; Cassetti E; Schaffer A; Coppo L; Marino P
Blood Coagul Fibrinolysis; 2014 Jan; 25(1):86-91. PubMed ID: 24126247
[TBL] [Abstract][Full Text] [Related]
16. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.
Chen BW; Liu JJ; Xing JH; Liu HD; Wei YZ; Xue XF; Gu HP; Tao HL
Clin Appl Thromb Hemost; 2022; 28():10760296221079334. PubMed ID: 35187964
[TBL] [Abstract][Full Text] [Related]
18. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
19. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
Xu X; Pandit RU; Han L; Li Y; Guo X
Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
[TBL] [Abstract][Full Text] [Related]
20. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
